or Try an Advanced Search...

    Topical Medication Stocks List

    Symbol Grade Name % Change
    ACRS B Aclaris Therapeutics, Inc. 6.06
    TENX C Tenax Therapeutics, Inc. -2.39
    ELAB F ELEVAI Labs, Inc. -5.61
    SLGL F Sol-Gel Technologies Ltd. 17.14
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Pharmaceutical Medicine Ointments Pharmacology Stage Specialty Pharmaceutical Brain Injury Carbon Products Cardiac Output Cardiac Surgery Chemical Substances Common Warts Cosmetic Products Dermatology Drug Products Healing Health Sciences Hydrogen Hydrogen Peroxide Ischemia Keratosis

    Related ETFs - A few ETFs which own one or more of the above listed Topical Medication stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.04
    BIB F ProShares Ultra Nasdaq Biotechnology 0.02
    IBBQ D Invesco Nasdaq Biotechnology ETF 0.02
    IBB D iShares Nasdaq Biotechnology Index Fund 0.02
    VTI A Vanguard Total Stock Market ETF 0.0
    View all Topical Medication ETFs...
    Compare ETFs
    Compare BIB to IBBQ Compare IBB to VTI Compare IWC to IBB

        Topical Medication Stocks Recent News

        Date Stock Title
        Nov 20 ACRS Aclaris upgraded to overweight by Cantor on in-licensing deal
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
        Nov 19 ACRS Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
        Nov 19 ACRS Aclaris stock soars for second day on licensing deal, analyst upgrades
        Nov 19 ACRS Aclaris Therapeutics secures global rights to Biosion’s antibodies
        Nov 19 ACRS ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
        Nov 18 ACRS Aclaris stock rallies 53% amid licensing deal, Piper upgrade
        Nov 18 ACRS Aclaris signs license deal for biologics assets
        Nov 18 ACRS Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
        Nov 18 ACRS Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
        Nov 18 ACRS Aclaris Therapeutics Announces $80 Million Private Placement
        Nov 17 ELAB Elevai Labs Third Quarter 2024 Earnings: US$0.068 loss per share (vs US$0.078 loss in 3Q 2023)
        Nov 17 SLGL Sol-Gel Technologies Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 SLGL Sol-Gel Technologies GAAP EPS of -$0.01 beats by $0.04, revenue of $5.36M beats by $1.16M
        Nov 15 SLGL Sol-Gel Technologies Ltd. (SLGL) Reports Q3 Loss, Tops Revenue Estimates
        Nov 15 SLGL Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
        Nov 14 ELAB CORRECTION - Elevai Labs Inc.
        Related Industries: Biotechnology
        Related Stock Lists: Pharmaceutical Medicine Ointments Pharmacology Stage Specialty Pharmaceutical Brain Injury Carbon Products Cardiac Output Cardiac Surgery Chemical Substances Common Warts Cosmetic Products Dermatology Drug Products Healing Health Sciences Hydrogen Hydrogen Peroxide Ischemia Keratosis
        Topical Medication

        Topical medication is a type of medication that is applied directly to the skin, mucous membranes, or other body surfaces. It is used to treat a variety of skin conditions, such as acne, eczema, psoriasis, and fungal infections. Topical medications can come in the form of creams, ointments, gels, lotions, and sprays.

        Browse All Tags